{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:14:24Z","timestamp":1766870064353},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,26]]},"DOI":"10.7759\/cureus.15937","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T13:08:39Z","timestamp":1624712919000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Virological Features of Acute Hepatic Exacerbations in Patients With Chronic Hepatitis B Virus Infection"],"prefix":"10.7759","author":[{"given":"Remzi","family":"Bestas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendal","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(85)80050-7","article-title":"Acute exacerbation in hepatitis B e antigen-positive chronic type B hepatitis: a clinicopathological study","volume":"1","author":"Liaw YF","year":"1985","unstructured":"Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis B e antigen-positive chronic type B hepatitis: a clinicopathological study. J Hepatol. 1985, 1:227-33. 10.1016\/S0168-8278(85)80050-7","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90069-4","article-title":"Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology","volume":"10","author":"Lok AS","year":"1990","unstructured":"Lok AS, Lai CL. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol. 1990, 10:29-34. 10.1016\/0168-8278(90)90069-4","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok AS","year":"2001","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2001, 34:1225-41. 10.1053\/jhep.2001.29401","journal-title":"Hepatology"},{"key":"ref4","article-title":"Hepatitis B virus reactivation associated with immunosuppression","author":"Lok AS","year":"2021","unstructured":"Lok AS, Bonis P. Hepatitis B virus reactivation associated with immunosuppression. UpToDate. Ted WP (ed): UpToDate, Waltham; 2021."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05924.x","article-title":"Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease","volume":"24","author":"Wong VW","year":"2009","unstructured":"Wong VW, Chan HL. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease. J Gastroenterol Hepatol. 2009, 24:1179-86. 10.1111\/j.1440-1746.2009.05924.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02976.x","article-title":"Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy","volume":"18","author":"Liaw YF","year":"2003","unstructured":"Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol. 2003, 18:246-52. 10.1046\/j.1440-1746.2003.02976.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00294-1","article-title":"Progress toward elimination of hepatitis B virus transmission in the United States","volume":"16","author":"Mast EE","year":"1998","unstructured":"Mast EE, Mahoney FJ, Alter MJ, Margolis HS. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine. 1998, 16:48-51. 10.1016\/S0264-410X(98)00294-1","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-004-3010-7","article-title":"Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey","volume":"32","author":"Yalcin K","year":"2004","unstructured":"Yalcin K, Degertekin H, Bahcecioglu IH, et al.. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey. Infection. 2004, 32:24-9. 10.1007\/s15010-004-3010-7","journal-title":"Infection"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01511.x","article-title":"A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East","volume":"19","year":"2012","unstructured":"A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012, 19.9-22. 10.1111\/j.1365-2893.2011.01511.x","journal-title":"J Viral Hepat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ph.1900684","article-title":"Horizontal transmission of HBV infection among students in Turkey","volume":"114","author":"Degertekin H","year":"2000","unstructured":"Degertekin H, Tuzcu A, Yalcin K. Horizontal transmission of HBV infection among students in Turkey. Public Health. 2000, 114:411-2. 10.1038\/sj.ph.1900684","journal-title":"Public Health"},{"key":"ref11","article-title":"Markers of disease activity in chronic hepatitis B virus infection","volume":"26","author":"Yalcin K","year":"2003","unstructured":"Yalcin K, Degertekin H, Yildiz F, Celik Y. Markers of disease activity in chronic hepatitis B virus infection. Clin Invest Med. 2003, 26:27-34.","journal-title":"Clin Invest Med"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/S1665-2681(19)31575-3","article-title":"Chronic HBV with pregnancy: reactivation flare causing fulminant hepatic failure","volume":"10","author":"Singhal A","year":"2011","unstructured":"Singhal A, Kanagala R, Jalil S, Wright HI, Kohli V. Chronic HBV with pregnancy: reactivation flare causing fulminant hepatic failure. Ann Hepatol. 2011, 10:233-6.","journal-title":"Ann Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2012.06.006","article-title":"Management of chemotherapy-induced hepatitis B virus reactivation","volume":"75","author":"Huang YH","year":"2012","unstructured":"Huang YH, Lin HC, Lee SD. Management of chemotherapy-induced hepatitis B virus reactivation. J Chin Med Assoc. 2012, 75:359-62. 10.1016\/j.jcma.2012.06.006","journal-title":"J Chin Med Assoc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310232","article-title":"Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen","volume":"31","author":"Marusawa H","year":"2000","unstructured":"Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology. 2000, 31:488-95. 10.1002\/hep.510310232","journal-title":"Hepatology"},{"key":"ref15","article-title":"Clinical features and natural course of HBV-related glomerulopathy in children","volume":"35","author":"Lin CY","year":"1991","unstructured":"Lin CY. Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int Suppl. 1991, 35:S46-53.","journal-title":"Kidney Int Suppl"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05600.x","article-title":"Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare","volume":"23","author":"Han Y","year":"2008","unstructured":"Han Y, Tang Q, Zhu W, Zhang X, You L. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. J Gastroenterol Hepatol. 2008, 23:1728-33. 10.1111\/j.1440-1746.2008.05600.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref17","article-title":"Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?","volume":"50","author":"Thakur V","year":"2002","unstructured":"Thakur V, Guptan RC, Malhotra V, Basir SF, Sarin SK. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?. J Assoc Physicians India. 2002, 50:1386-94.","journal-title":"J Assoc Physicians India"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-3175-2","article-title":"Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B","volume":"51","author":"Kumar M","year":"2006","unstructured":"Kumar M, Jain S, Sharma BC, Sarin SK. Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci. 2006, 51:594-9. 10.1007\/s10620-006-3175-2","journal-title":"Dig Dis Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2005.20.1.80","article-title":"Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma","volume":"20","author":"Bae JS","year":"2005","unstructured":"Bae JS, Park SJ, Park KB, Paik SY, Ryu JK, Choi CK, Hwang TJ. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma. Korean J Intern Med. 2005, 20:80-5. 10.3904\/kjim.2005.20.1.80","journal-title":"Korean J Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20383","article-title":"Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B","volume":"40","author":"Garfein RS","year":"2004","unstructured":"Garfein RS, Bower WA, Loney CM, et al.. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology. 2004, 40:865-73. 10.1002\/hep.20383","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i43.5447","article-title":"Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients","volume":"16","author":"Brost S","year":"2010","unstructured":"Brost S, Schnitzler P, Stremmel W, Eisenbach C. Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients. World J Gastroenterol. 2010, 16:5447-51. 10.3748\/wjg.v16.i43.5447","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour DR","year":"2000","unstructured":"Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem. 2000, 46:2050-68. 10.1093\/clinchem\/46.12.2050","journal-title":"Clin Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.06.011","article-title":"Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B","volume":"37","author":"Rodella A","year":"2006","unstructured":"Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol. 2006, 37:206-12. 10.1016\/j.jcv.2006.06.011","journal-title":"J Clin Virol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle JH","year":"2009","unstructured":"Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009, 49:S156-65. 10.1002\/hep.22945","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02396.x","article-title":"The difficulties of managing severe hepatitis B virus reactivation","volume":"31 Suppl 1","author":"Roche B","year":"2011","unstructured":"Roche B, Samuel D. The difficulties of managing severe hepatitis B virus reactivation. Liver Int. 2011, 31 Suppl 1:104-10. 10.1111\/j.1478-3231.2010.02396.x","journal-title":"Liver Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06243.x","article-title":"Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management","volume":"25","author":"Lubel JS","year":"2010","unstructured":"Lubel JS, Angus PW. Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management. J Gastroenterol Hepatol. 2010, 25:864-71. 10.1111\/j.1440-1746.2010.06243.x","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/62096-clinical-and-virological-features-of-acute-hepatic-exacerbations-in-patients-with-chronic-hepatitis-b-virus-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:24Z","timestamp":1707506724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/62096-clinical-and-virological-features-of-acute-hepatic-exacerbations-in-patients-with-chronic-hepatitis-b-virus-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.15937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,26]]}}}